GGrantIndex
← Leaderboards

Curtis Pickering

University Of Tx Md Anderson Can Ctr

$3,428,543
Attributed
$6,537,086
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201925
$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,537,086 · 3

By mechanism

R01$6,217,086 · 2
R03$320,000 · 1

Top collaborators

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Genomics

Research focus

GenomicsCellsGenomic BiomarkerBiological MarkersClinical TrialsPatient CareCell TypePrognostic MarkerProspectiveProtocols DocumentationNew Therapeutic TargetMalignant NeoplasmsCell LineGenesHead And Neck Squamous Cell CarcinomaDna Sequence AlterationCohortExperimental StudyBiologyFutureIn VitroGenomic DataIn VivoRadiation Therapy

Grant awards (12)

Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders$684,002
R01 · FY2025 · DE · contact PI
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders$670,324
R01 · FY2024 · DE · contact PI
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders$684,002
R01 · FY2023 · DE · contact PI
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma$563,756
R01 · FY2023 · DE · contact PI
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders$670,360
R01 · FY2022 · DE · contact PI
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma$558,118
R01 · FY2022 · DE · contact PI
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders$691,555
R01 · FY2021 · DE · contact PI
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma$563,756
R01 · FY2021 · DE · contact PI
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma$563,756
R01 · FY2020 · DE · contact PI
Genomic Stratification and Targeting of HPV+ Cancer$160,000
R03 · FY2020 · DE · contact PI
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma$567,457
R01 · FY2019 · DE · contact PI
Genomic Stratification and Targeting of HPV+ Cancer$160,000
R03 · FY2019 · DE · contact PI